Welcome to the News & More section. Here you will find general information in the form of press releases, news and the latest graphical material.
Berlin-Chemie has been developing, manufacturing and distributing pharmaceutical products for over 130 years and has been a wholly owned subsidiary of the Menarini Group, the leading Italian pharmaceutical company, since 1992.
Responsibility is a top priority at Berlin-Chemie. We not only make an important contribution to healthcare, but also put our values into practice through various social initiatives.
From school kits to free meals and medicines, to caring for the environment around the world. In Menarini, being responsible means translating our values into concrete actions that are good for others and good for the planet
Berlin-Chemie – a strong partner. Our many years of experience and the success of joint projects make us the partner of choice.
Menarini has in-depth know-how in many important therapeutic areas, thanks to many years of excellent market introduction, marketing and sales capabilities as well as expertise in regulatory aspects and market access. Collaboration is the key to great success, and at Menarini, partnership is part of the DNA.
Our holistic and professional health management offers doctors individual counselling, training or workshops, events and lectures on many topics, depending on their needs.
Our Medical Hub acts as a central point of contact for doctors and healthcare professionals. Here you will find all the information about our medications, additional service and training opportunities.
Welcome to the News & More section. Here you will find general information in the form of press releases, news and the latest graphical material.
We employ professionals with a wide variety of career backgrounds and are employers who care about their staff. Together, we stand for innovation and reliability.
Find out about our current vacancies at Berlin-Chemie directly on our career portal.
Within the Menarini Group, Berlin-Chemie is the regional headquarters for the CEE and CIS region and is responsible for more than 30 countries and their local subsidiaries.
As a reliable partner in the healthcare sector, we want to use our products and expertise to help solve the complex challenges in the healthcare sector in these regions. To this end, Berlin-Chemie has established strong partnerships at all levels in many countries. We support doctors and patients with high-quality medical products and technologies to improve the quality of life.
BERLIN-CHEMIE AG
Glienicker Weg 125
12489 Berlin, Deutschland
E-mail: info@berlin-chemie.de
Phone: +49 (0)30 6707-0
Fax: +49 (0)30 6707-2120
2016 - 12 - 02
Press Release
Florence, 02 December 2016: Menarini pharmaceuticals demonstrates a positive trend in the first 10 months of 2016, with 250 new employees in Italy and 230 around the world.
The average age of the new employees is 29. The new hires are 60% male and 40% female and all of them are highly qualified with degrees or technical diplomas, and they join a total of over 16,000 staff in 130 countries around the world. In Italy, Menarini has manufacturing sites, research centres and offices in Florence, Pisa, Milan, L’Aquila, Pomezia, Bologna and Rapolano Terme (Siena).
The employment horizon within the Florentine pharmaceuticals company is very broad, from production of extremely high-quality medicinal products in 15 sites in various countries to research in oncology and new technologies in the field of vaccines.
The company will continue to look for qualified personnel for its head office in Florence, but also for the other manufacturing sites, research centres and offices in Italy, such as L’Aquila, Pisa, Milan, Pomezia, Bologna and Rapolano Terme (Siena).
“In the last few months we have acquired a chemical plant in Lombardy, called Lodichem, which we are relaunching; we have created VaxYnethic in Tuscany, a competitive joint venture which develops innovative technologies for the production of vaccines; we have strengthened our branches and offices around the world; and we have signed research contracts with leading global companies. We have taken on the challenge of growth” – stated Lucia Aleotti and Alberto Giovanni Aleotti, Chairman and Vice Chairman of the Menarini Group. “These new employees are a very positive consequence of this process”.